GlobeNewsWire
12 Oct 2026, 17:49 UTC · 1h ago
UNCY Shareholder Alert: November 2, 2026 Lead Plaintiff Deadline in Unicycive Therapeutics, Inc. Securities Class Action - Contact Levi & Korsinsky
Impact · against what's priced in
The announcement of a lead plaintiff deadline for the securities class action against Unicycive Therapeutics is a procedural update to an existing legal threat. The underlying allegations regarding FDA compliance verification failures are the primary drivers of risk and do not introduce new fundamental shocks.
- UCYV−0.20
No priced-in read yet





